DRK deserves to rise, but the lack of volume means its anyones game. one puff and it can all fall down! need news - my trading strategy went out the door as i expected DRK to come out with news before RXL!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
